Connect with us

Health

Rapid CD169 assay for COVID-19 screening – News-Medical.Net

Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory…

Published

on

post featured image
ADVERTISEMENT

Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The assay detects the upregulation of whole blood monocyte CD169, which has been reported as a marker of viral infections.
This rapid assay was more sensitive than the currently used method and less likely to produce false-negative results, especially among early and asymptomatic patients.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

New technique may help assess hand injuries – News-Medical.Net
Too many childcare workers don’t know how to ensure kids get daily dose of exercise: Telethon Kids Institute – WAtoday